MK

Mathew Kokad Thomas

Director Director DIN 01870198
DIN 01870198 First appointment Dec 2007 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2007
Shareholding value Locked Premium profile

About Mathew Kokad Thomas

Mathew Kokad Thomas has 18 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 01870198
Primary Designation Director
First Appointment 10 Dec 2007
Oldest Company Age 31 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Kokad Pharmaceuticals Ltd U24231KL1995PLC008693
Director 10 Dec 2007 1995 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kokad Pharmaceuticals Ltd
Premium access

Shareholding and investment profile for Mathew Kokad Thomas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mathew Kokad Thomas

Mathew Kokad Thomas has 18 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Mathew Kokad Thomas is associated with 0 companies as Director.

Mathew Kokad Thomas has expertise in General Business.

Mathew Kokad Thomas has 18 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available